News & Updates

Show Multimedia Only

Varenicline helps T2D patients quit smoking

29 Jun 2022 by

Use of varenicline in a smoking cessation program for patients with type 2 diabetes (T2D) is safe and effective, facilitating long-term abstinence without adverse consequences, according to the results of a trial.

Varenicline helps T2D patients quit smoking

29 Jun 2022

Inability to stand on a leg for 10 sec tied to shorter life in older adults

27 Jun 2022 by

Inability to stand on one leg for 10 seconds (sec) is strongly linked to a higher risk of death, and consequently, a shorter life expectancy in older adults, according to a study in Brazil.

Inability to stand on a leg for 10 sec tied to shorter life in older adults

27 Jun 2022

Regular statin use offers protection against diabetes in acute pancreatitis patients

27 Jun 2022

Regular statin users appear to be at lower risk of developing diabetes mellitus following an episode of acute pancreatitis, as shown in a study.

Regular statin use offers protection against diabetes in acute pancreatitis patients

27 Jun 2022

Glargine, degludec improve glycaemic control in patients switching from first-gen insulin

27 Jun 2022

Among type 2 diabetes (T2D) patients on first-generation basal insulins (1BIs), a switch to either glargine or degludec in the real-world setting leads to marked improvements in glucose control without increasing the risk of hypoglycaemic events and weight gain, according to a study. Furthermore, the benefits seem to be comparable between the two second-generation basal insulins (2BIs).

Glargine, degludec improve glycaemic control in patients switching from first-gen insulin

27 Jun 2022

Calorie restriction blunts long-term kidney decline, improves CV risk factors in obese T2D patients

26 Jun 2022

In type 2 diabetes (T2D) patients with obesity, calorie restriction helps correct several cardiovascular (CV) risk factors and glomerular hyperfiltration, with the latter translating into a relative long-term stabilization of kidney function, according to a study.

Calorie restriction blunts long-term kidney decline, improves CV risk factors in obese T2D patients

26 Jun 2022

Tirzepatide: A winning weight-loss therapy for nondiabetic, obese adults

25 Jun 2022 by

Non-diabetic overweight or obese adults experienced a greater reduction in weight and cardiometabolic measures with the addition of tirzepatide to their lifestyle interventions, findings of the SURMOUNT-1 trial showed.

Tirzepatide: A winning weight-loss therapy for nondiabetic, obese adults

25 Jun 2022

SGLT2is reduce serious hyperkalaemia risk in T2D, CKD patients

23 Jun 2022 by

Sodium-glucose cotransporter 2 inhibitors (SGLT2is) consistently reduced the risk of serious hyperkalaemia (serum potassium [K+] ≥6.0 mmol/L) without increasing the risk of hypokalaemia (serum K+ ≤3.5 mmol/L) in individuals with type 2 diabetes (T2D) at high cardiovascular (CV) risk, or in those with chronic kidney disease (CKD), a meta-analysis has shown.

SGLT2is reduce serious hyperkalaemia risk in T2D, CKD patients

23 Jun 2022

Late-afternoon intake of high-energy supplements may do more harm than good in women

22 Jun 2022 by

Women with lower body mass index (BMI) who consume high-energy oral nutritional supplements (ONS) late in the afternoon experience only a partial and short-lived energy intake suppression, which increases their total energy intake but has a harmful effect on measures of insulin sensitivity, results of a study have shown.

Late-afternoon intake of high-energy supplements may do more harm than good in women

22 Jun 2022

NAFLD linked to heightened type 2 diabetes risk

22 Jun 2022

Children with nonalcoholic fatty liver disease (NAFLD) are at an increased risk of type 2 diabetes, a study reports. Other risk factors for T2D include severity of liver histology, body mass index, and female sex.

NAFLD linked to heightened type 2 diabetes risk

22 Jun 2022

Rapid childhood growth rate tied to elevated risk of islet autoimmunity, T1D development

21 Jun 2022 by

Children who grow in height fast appears to have a higher risk of islet autoimmunity (IAA) and rapid progression to type 1 diabetes (T1D), a study has found.

Rapid childhood growth rate tied to elevated risk of islet autoimmunity, T1D development

21 Jun 2022

News & Updates

Showing Endocrinology articles

Showing

Specialty:

Varenicline helps T2D patients quit smoking

Varenicline helps T2D patients quit smoking

Inability to stand on a leg for 10 sec tied to shorter life in older adults

Inability to stand on a leg for 10 sec tied to shorter life in older adults

Regular statin use offers protection against diabetes in acute pancreatitis patients

Regular statin use offers protection against diabetes in acute pancreatitis patients

Glargine, degludec improve glycaemic control in patients switching from first-gen insulin

Glargine, degludec improve glycaemic control in patients switching from first-gen insulin

Calorie restriction blunts long-term kidney decline, improves CV risk factors in obese T2D patients

Calorie restriction blunts long-term kidney decline, improves CV risk factors in obese T2D patients

Tirzepatide: A winning weight-loss therapy for nondiabetic, obese adults

Tirzepatide: A winning weight-loss therapy for nondiabetic, obese adults

SGLT2is reduce serious hyperkalaemia risk in T2D, CKD patients

SGLT2is reduce serious hyperkalaemia risk in T2D, CKD patients

Late-afternoon intake of high-energy supplements may do more harm than good in women

Late-afternoon intake of high-energy supplements may do more harm than good in women

NAFLD linked to heightened type 2 diabetes risk

NAFLD linked to heightened type 2 diabetes risk

Rapid childhood growth rate tied to elevated risk of islet autoimmunity, T1D development

Rapid childhood growth rate tied to elevated risk of islet autoimmunity, T1D development